Alessia Cavo - Dissemin

Language
Login

All papers authored by Alessia Cavo

This paper is made freely available by the publisher.

2023 Marco Stellato

ORCID

, Sebastiano Buti

ORCID

, Marco Maruzzo

ORCID

, Melissa Bersanelli

ORCID

, Francesco Pierantoni

ORCID

, Ugo De Giorgi

ORCID

, Marilena Di Napoli, Roberto Iacovelli, Maria Giuseppa Vitale

ORCID

, Paola Ermacora, Andrea Malgeri, Brigida Anna Maiorano

ORCID

, Veronica Prati, Alessia Mennitto

ORCID

, Alessia Cavo

ORCID

and 6 other authors

Pembrolizumab Plus Axitinib for Metastatic Papillary and Chromophobe Renal Cell Carcinoma: NEMESIA (Non Clear MEtaStatic Renal Cell Carcinoma Pembrolizumab Axitinib) Study, a Subgroup Analysis of I-RARE Observational Study (Meet-URO 23a)

Download from doi.org

This paper is made freely available by the publisher.

2021 Manlio Mencoboni, Marcello Ceppi, Marco Bruzzone

ORCID

, Paola Taveggia, Alessia Cavo

ORCID

, Francesca Scordamaglia, Marina Gualco, Rosa Angela Filiberti

ORCID

Effectiveness and Safety of Immune Checkpoint Inhibitors for Patients with Advanced Non Small-Cell Lung Cancer in Real-World: Review and Meta-Analysis

Download from doi.org

This paper is made freely available by the publisher.

Sara Elena Rebuzzi

ORCID

, Alessio Signori, Giuseppe Luigi Banna

ORCID

, Marco Maruzzo

ORCID

, Ugo De Giorgi

ORCID

, Paolo Pedrazzoli, Andrea Sbrana

ORCID

, Paolo Andrea Zucali, Cristina Masini, Emanuele Naglieri, Giuseppe Procopio, Sara Merler

ORCID

, Laura Tomasello, Lucia Fratino, Cinzia Baldessari and 30 other authors

Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study)

Download from doi.org

This paper is made freely available by the publisher.

2019 Matteo Bauckneht

ORCID

, Selene Capitanio, Maria Isabella Donegani, Elisa Zanardi

ORCID

, Alberto Miceli

ORCID

, Roberto Murialdo, Stefano Raffa, Laura Tomasello, Martina Vitti, Alessia Cavo

ORCID

, Fabio Catalano, Manlio Mencoboni, Marcello Ceppi, Cecilia Marini, Giuseppe Fornarini and 3 other authors

Role of Baseline and Post-Therapy 18F-FDG PET in the Prognostic Stratification of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated with Radium-223

Download from doi.org

This paper is made freely available by the publisher.

2018 Alessia Cavo

ORCID

, Alessandra Rubagotti, Elisa Zanardi, Chiara Fabbroni, Linda Zinoli, Antonio Di Meglio, Eleonora Arboscello, Andrea Bellodi, Paolo Spallarossa, Carlo Cattrini

ORCID

, Carlo Messina, Francesco Boccardo

Abiraterone acetate and prednisone in the pre- and post-docetaxel setting for metastatic castration-resistant prostate cancer: a mono-institutional experience focused on cardiovascular events and their impact on clinical outcomes

Download from journals.sagepub.com

Missing publications? Search for publications with a matching author name.